Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.28−0.05 (-3.76%)
Close on Nov 13, 2026Market cap $217.02MP/E –Yield –
Cabaletta Bio EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$2.10. The highest annual figure on record is -$1.44 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.10 | – |
| FY2024 | Dec 31, 2024 | -$2.34 | – |
| FY2023 | Dec 31, 2023 | -$1.65 | – |
| FY2022 | Dec 31, 2022 | -$1.81 | – |
| FY2021 | Dec 31, 2021 | -$1.80 | – |
| FY2020 | Dec 31, 2020 | -$1.44 | – |
| FY2019 | Dec 31, 2019 | -$4.07 | – |
| FY2018 | Dec 31, 2018 | -$6.87 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.28 | – |
| Q2 FY2026 | Jun 30, 2026 | -$0.34 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.39 | – |
| Q3 FY2025 | Sep 30, 2025 | -$0.44 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.73 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.71 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.62 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.56 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.51 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.37 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.37 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.45 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.39 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.45 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.45 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.45 | – |
| Q2 FY2021 | Jun 30, 2021 | -$0.45 | – |
| Q1 FY2021 | Mar 31, 2021 | -$0.41 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.36 | – |
| Q2 FY2020 | Jun 30, 2020 | -$0.35 | – |
| Q1 FY2020 | Mar 31, 2020 | -$0.33 | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.17 | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.87 | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.05 | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.47 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?